14 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 35489270 | Targeting the interplay between MMP-2, CA II and VEGFR-2 via new sulfonamide-tethered isomeric triazole hybrids; Microwave-assisted synthesis, computational studies and evaluation. | 2022 Jul | 2 |
2 | 32459093 | Tumor Microenvironment-Responsive, Multistaged Liposome Induces Apoptosis and Ferroptosis by Amplifying Oxidative Stress for Enhanced Cancer Therapy. | 2020 Jul 8 | 1 |
3 | 29328399 | miR‑378a enhances the sensitivity of liver cancer to sorafenib by targeting VEGFR, PDGFRβ and c‑Raf. | 2018 Mar | 1 |
4 | 30272354 | Capsaicin and sorafenib combination treatment exerts synergistic anti‑hepatocellular carcinoma activity by suppressing EGFR and PI3K/Akt/mTOR signaling. | 2018 Dec | 1 |
5 | 30499465 | Rho GTPase Activating Protein 24 (ARHGAP24) Regulates the Anti-Cancer Activity of Sorafenib Against Breast Cancer MDA-MB-231 Cells via the Signal Transducer and Activator of Transcription 3 (STAT3) Signaling Pathway. | 2018 Nov 30 | 1 |
6 | 31259702 | The Transcription Factor Creb is Involved in Sorafenib-Inhibited Renal Cancer Cell Proliferation, Migration and Invasion. | 2018 Dec 1 | 1 |
7 | 28276313 | Inhibition of MMP-2 Expression Enhances the Antitumor Effect of Sorafenib in Hepatocellular Carcinoma by Suppressing the PI3K/AKT/mTOR Pathway. | 2017 Nov 2 | 5 |
8 | 28746469 | Interleukin-27 augments the inhibitory effects of sorafenib on bladder cancer cells. | 2017 Jul 20 | 1 |
9 | 27998073 | Matrix Metalloproteinase Responsive Nanoparticles for Synergistic Treatment of Colorectal Cancer via Simultaneous Anti-Angiogenesis and Chemotherapy. | 2016 Dec 21 | 2 |
10 | 25557114 | Sorafenib inhibits proliferation and invasion of human hepatocellular carcinoma cells via up-regulation of p53 and suppressing FoxM1. | 2015 Feb | 2 |
11 | 25862849 | Sorafenib inhibits migration and invasion of hepatocellular carcinoma cells through suppression of matrix metalloproteinase expression. | 2015 Apr | 1 |
12 | 26244291 | Regulation of ADAM10 and ADAM17 by Sorafenib Inhibits Epithelial-to-Mesenchymal Transition in Epstein-Barr Virus-Infected Retinal Pigment Epithelial Cells. | 2015 Aug | 1 |
13 | 22918681 | Antifibrotic activity of sorafenib in experimental hepatic fibrosis: refinement of inhibitory targets, dosing, and window of efficacy in vivo. | 2013 Jan | 1 |
14 | 23658488 | Preclinical evaluation of sorafenib-eluting stent for suppression of human cholangiocarcinoma cells. | 2013 | 2 |